CSPIA
DNA icon

Cary Street Partners Investment Advisory’s Ginkgo Bioworks DNA Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29
Closed -$2.13K – 906
2023
Q3 		$2.13K Buy
+29
New +$2.32K ﹤0.01% 1651

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cary Street Partners Investment Advisory's DNA Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 29 shares — an estimated $2.13K sold.

Cary Street Partners Investment Advisory first reported a position in DNA in Q3 2023 and held it in 1 quarter. The position peaked at $2.13K in Q3 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 29 Ginkgo Bioworks shares in Q4 2023, an estimated $2.13K.
  • Cary Street Partners Investment Advisory first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 1 quarter.
  • Cary Street Partners Investment Advisory's Ginkgo Bioworks position peaked at $2.13K in Q3 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.